Goldman Sachs FICC Revenue Falls 10% Amid Iran War Market Volatility 
Elon Musk's Terafab Foundry Courts Top Chipmaking Giants for AI Self-Sufficiency Push 
KKR's $820M Investment Fuels Samsung SDS AI Expansion, Sending Group Shares Soaring 
Apple Wins ITC Ruling, Keeping Blood-Oxygen Feature on Apple Watch 
AEVEX Raises $320 Million in IPO Amid Surging Defense Sector Demand 
NVIDIA Acquisition Rumors Dismissed by Morgan Stanley as Strategically Flawed 
Federal Judge Dismisses DOJ Lawsuit Attempting to Block Hawaii's Climate Case Against Oil Giants 
Anthropic CEO Meets Trump Officials to Discuss Powerful New AI Model Mythos 
Japan Opens Arms Export Floodgates: New Policy Draws Global Defense Interest 
Want to cut your energy bills? Here’s how five experts are doing it 
Samsung Races to Deliver Next-Gen HBM4E Memory Samples to Nvidia 
How Technology Is Reshaping Modern Business: From Operations to Customer Experience 
NiSource Signs Long-Term Energy Deals with Alphabet and Amazon to Power Indiana Data Centers 
Sam Altman Moves to Dismiss Punitive Damages in Sister's Sexual Abuse Lawsuit 
OpenAI's $20 Billion Cerebras Deal Signals Massive AI Infrastructure Push 
Federal Agencies Secretly Test Anthropic's AI Despite Trump Administration Ban 
TSMC Posts Record Q1 Profit Fueled by AI Chip Demand 
SAN CLEMENTE, Calif., June 01, 2017 -- David Steenblock, an osteopathic physician based in San Clemente, CA, is uniquely qualified to address toxicity in the human body through his use of EDTA Chelation Therapy.
Dr. Steenblock uses EDTA (EthyleneDiamineTetraAcetic Acid) Chelation Therapy, a procedure that removes heavy metals from the blood, and consistently improves blood flow and relieves symptoms associated with atherosclerosis in over 80% of patients treated.
“It’s been observed that patients being treated for acute lead intoxification with EDTA with cardiovascular disease, showed improved stress tolerance and less chest pain with physical exertion, “ said Dr. Steenblock.
Dr. Steenblock believes that the benefits of EDTA chelation can improve circulation; reduce cholesterol levels, decrease high blood pressure; and lower insulin requirements in diabetics.
In addition, Dr. Steenblock uses EDTA Chelation Therapy with a combination of hyperbaric oxygen therapy, leading to significant neurologic improvements for stroke patients.
Dr. David Steenblock is a leading-edge physician in many fields of medicine, from stroke care, to acute brain trauma, to generative and cell-based medicine in the treatment of ALS, Cerebral Palsy and other chronic and degenerative diseases. For more information about Dr. Steenblock’s work in stem cell therapies, visit www.stemcellmd.org.
CONTACT: Irene Doti [email protected]
